(Press-News.org) PORTLAND, Ore. — For decades, a successful HIV vaccine has been the Holy Grail for researchers around the globe. Yet despite years of research and millions of dollars of investment, that goal has still yet to be achieved. Recent research by Oregon Health & Science University scientists explains a decades-old mystery as to why slightly weakened versions of the monkey AIDS virus were able to prevent subsequent infection with the fully virulent strain, but were too risky for human use, and why severely compromised or completely inactivated versions of the virus were not effective at all.
The research was conducted at OHSU's Vaccine and Gene Therapy Institute and is published online in the journal Nature Medicine.
Traditionally, there have been two methods for creating vaccines to combat infectious disease. The first approach utilizes a live, yet weakened strain of the disease in question. This weakened strain is not strong enough to cause illness yet potent enough to activate the immune system so that it can detect and fight a disease if it enters the body in the future. The second approach makes use of a dead form of the disease. As with the other approach, the introduction of the disease in a safe form educates and prepares the body for a possible future invasion.
In the early 1990s, a slightly weakened version of SIV, the monkey counterpart to HIV, was shown to protect monkeys for infection with the fully virulent version, but this weakened version was still able to cause AIDS in some monkeys and the protection was lost if the vaccine virus was further weakened.
"Efforts to develop a live attenuated virus are analogous to the tale of 'Goldilocks and the Three Bears,'" explained Louis Picker, M.D., associate director of the OHSU Vaccine and Gene Therapy Institute. "The field was looking for a vaccine that was 'not too hot,' or 'not too cold,' but 'just right.' The problem was that it appears that weakening a virus to the level that is 'just right' is impossible. However, we thought that understanding the mechanism responsible for the protection afforded by the too-dangerous-for clinical-use attenuated vaccine would allow us to design a vaccine that would be both effective and safe".
The newly published research shows that the protection is due to anti-viral T cells maintained in lymphoid tissue by persistent live attenuated virus; weakening the virus prevents this persistence and curtails protection. Thus, unlike most vaccines, an effective HIV vaccine might have to persist in the body to be effective.
Picker's group has developed another persistent virus named cytomegalovirus (CMV) engineered to express SIV or HIV proteins and serve as the transport system (vector) used to raise protective immune responses against these AIDS-causing viruses. In May 2011, the Picker lab published findings that demonstrated how immune responses elicited by their vaccine candidate were able to completely control SIV in a significant number of exposed animals.
CMV is a persistent virus that most people carry, causes few or no symptoms, and elicits very strong cellular responses that are maintained for life. These immune responses are characterized by a type of T cell called an effector memory T cell that has potent anti-viral function and localizes in the same tissues targeted by the AIDS-causing viruses. Picker and his team hypothesize that CMV vector-generated anti-HIV responses would be constantly on the alert for HIV and would be able to intercept and stop HIV infection immediately after exposure.
###
The Bill and Melinda Gates Foundation, the International AIDS Vaccine Initiative and the National Institutes of Health funded this research.
About OHSU
Oregon Health & Science University is the state's only academic health and research university. As Portland's largest employer with nearly 14,000 employees, OHSU's size contributes to its ability to provide many services and community support not found anywhere else in the state. OHSU serves patients from every corner of Oregon and is a conduit for learning for more than 4,300 students and trainees. OHSU is the source of more than 200 community outreach programs that bring health and education services to each county in the state.
END
A nationwide consortium of scientists has reported the first comprehensive genetic analysis of squamous cell carcinoma of the lung, a common type of lung cancer responsible for about 400,000 deaths each year.
"We found that almost 75 percent of the patients' cancers have mutations that can be targeted with existing drugs -- drugs that are available commercially or for clinical trials," says one of the lead investigators, Ramaswamy Govindan, MD, an oncologist at Washington University School of Medicine in St. Louis and co-chair of the lung cancer group of The Cancer Genome ...
An international team of scientists have shown at an unprecedented level of detail how cells prioritise the repair of genes containing potentially dangerous damage. The research, published in the journal Nature and involving academics from the University of Bristol, the Institut Jacques-Monod in France and Rockefeller University in the US, studied the action of individual molecules in order to understand how cellular repair pathways are triggered.
The genetic information that forms the "instruction booklet" for cells is encoded in the molecular building blocks of DNA, ...
Mercury, when dumped in lakes and rivers, accumulates in fish, and often ends up on our plates. A Swiss-American team of researchers led by Francesco Stellacci at the Ecole Polytechnique Fédérale de Lausanne (EPFL) and Bartosz Grzybowski at Northwestern University has devised a simple, inexpensive system based on nanoparticles, a kind of nano-velcro, to detect and trap this toxic pollutant as well as others. The particles are covered with tiny hairs that can grab onto toxic heavy metals such as mercury and cadmium. This technology makes it possible to easily and inexpensively ...
In the September 9, 2012 early online edition of Nature, scientists with The Cancer Genome Atlas (TCGA) report that they have characterized the lung squamous cell carcinoma genome.
Squamous cell carcinoma is the second most common form of lung cancer, a disease that kills more Americans than any other type of cancer.
The national team of scientists examined tumor samples from 178 patients with untreated lung squamous cell carcinoma and completed genetic analysis of the tumors, work that paves the way for developing better, more targeted therapies to treat the cancer. ...
Cambridge and Boston, MA. Sunday, September 9, 2012 – A new paper published online in Nature holds out hope that people with the second most common type of lung cancer may one day benefit from targeted therapies that have transformed treatments for other lung cancer patients.
Squamous cell lung cancer kills more people each year than breast, colorectal, or prostate cancer, ranking second only to lung adenocarcinoma in the number of deaths it causes. But unlike the most common form of lung cancer, squamous cell carcinoma has no treatments aimed at the specific genetic ...
University Hospitals Case Medical Center clinical researchers will present findings about a one-two punch to prevent colds and flu in San Francisco at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) on Sept. 9.
The research team is presenting data in two poster presentations that a new oral antiseptic spray is effective in killing 99.9 percent of infectious airborne germs. Findings from these two presentations led to the development of Halo Oral Antiseptic, a first-of-its kind germ-fighting spray which is currently on store shelves.
"Respiratory ...
Mange and viral diseases have a substantial, recurring impact on the health and size of reintroduced wolf packs living in Yellowstone National Park, according to ecologists.
Following the restoration of gray wolves to Yellowstone in 1996, researchers collected blood from the animals to monitor parasite-induced disease and death. They also tracked the wolves in each pack to follow their survival and allow additional data-gathering.
"Many invasive species flourish because they lack their native predators and pathogens, but in Yellowstone we restored a native predator ...
Washington, D.C.— Over the past two decades, extensive forest death triggered by hot and dry climatic conditions has been documented on every continent except Antarctica. Forest mortality due to drought and heat stress is expected to increase due to climate change. Although research has focused on isolated incidents of forest mortality, little is known about the potential effects of widespread forest die-offs. A new analysis of the current literature on this topic by Carnegie's William and Leander Anderegg is published September 9 in Nature Climate Change.
Along with ...
Washington, D.C.— There is enough energy available in winds to meet all of the world's demand. Atmospheric turbines that convert steadier and faster high-altitude winds into energy could generate even more power than ground- and ocean-based units. New research from Carnegie's Ken Caldeira examines the limits of the amount of power that could be harvested from winds, as well as the effects high-altitude wind power could have on the climate as a whole. Their work is published September 9 by Nature Climate Change.
Led by Kate Marvel of Lawrence Livermore National Laboratory, ...
A new study from the University of Southern California (USC) has found a link between recreational marijuana use and an increased risk of developing subtypes of testicular cancer that tend to carry a somewhat worse prognosis. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings suggest that the potential cancer-causing effects of marijuana on testicular cells should be considered not only in personal decisions regarding recreational drug use, but also when marijuana and its derivatives are used for therapeutic purposes in ...
